LanzaTech Global to spin out LanzaX to focus on synthetic biology platform
In Illinois, LanzaTech Global announced its intent to form LanzaX, a business unit dedicated to its wholly-owned synthetic biology platform. LanzaTech intends to spin out LanzaX from its core biorefining business as a joint venture with Tharsis Capital LLC in the coming months. The Company also announced the appointment of Justin Pugh as Interim Chief […]
